Keywords: Antineoplastic Agent, Formylpeptide Receptor Like 1, Serylarginylserylarginyltyrosine, Unclassified Drug, Urokinase Receptor, Animal Cell, Antineoplastic Activity, Article, Binding Affinity, Binding Site, Cell Function, Cell Motility, Concentration Response, Controlled Study, Cyclization, Drug Determination, Drug Effect, Drug Mechanism, Drug Protein Binding, High Performance Liquid Chromatography, Human, Human Cell, Migration Inhibition, Molecular Dynamics, Monocyte, Nonhuman, Protein Determination, Protein Function, Sequence Analysis, Mammalia, Rattus,
Affiliations: *** IBB - CNR ***
Department of Pharmacy, University Federico II, Naples, Italy
Neoplastic Progression Unit, Department of Experimental Oncology, IRCCS Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy
SUN Second University of Naples, Italy
University 'Parthenope', Naples, Italy
CIRPEB: Centro Interuniversitario di Ricerca Sui Peptidi Bioattivi University of Naples Federico II, DFM-Scarl, Institute of Biostructures and Bioimaging - CNR, Naples, Italy
References: Plesner, T., Behrendt, N., Ploug, M., Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR (1997) Stem Cells, 15, pp. 398-408. , PMID: 940265
Mondino, A., Blasi, F., uPA and uPAR in fibrinolysis, immunity and pathology (2004) Trends Immunol, 25, pp. 450-455. , PMID: 15275645
Gyetko, M.R., Sud, S., Kendall, T., Fuller, J.A., Newstead, M.W., Standiford, T.J., Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection (2000) J Immunol, 165, pp. 1513-1519. , PMID: 10903758
Rijneveld, A.W., Levi, M., Florquin, S., Speelman, P., Carmeliet, P., Van Der Poll, T., Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia (2002) J Immunol, 168, pp. 3507-3511. , PMID: 11907112
Gyetko, M.R., Aizenberg, D., Mayo-Bond, L., Urokinase deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro (2004) Leukoc Biol, 76, pp. 648-656. , PMID: 15240745
Montuori, N., Selleri, C., Ragno, P., The urokinase-receptor in infectious diseases (2012) Infez Med, 20, pp. 8-12. , PMID: 23042000
Thunø, M., Macho, B., Eugen-Olsen, J., SuPAR the molecular crystal ball (2009) Dis Markers, 27, pp. 157-172. , PMID: 19893210
Huttunen, R., Syrjänen, J., Vuento, R., Hurme, M., Huhtala, H., Laine, J., Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: A prospective cohort study (2011) J Intern Med, 270, pp. 32-40. , PMID: 21332843
Ploug, M., Rønne, E., Behrendt, N., Jensen, A.L., Blasi, F., Danø, K., Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol (1991) J Biol Chem, 266, pp. 1926-1933. , PMID: 1846368
Ploug, M., Ellis, V., Structure-function relationships in the receptor for urokinase-type plasminogen activator-comparison to other members of the Ly-6 family and snake venom alpha- neurotoxins (1994) FEBS Lett, 349, pp. 163-168. , PMID: 8050560
Bifulco, K., Votta, G., Ingangi, V., Di Carluccio, G., Rea, D., Losito, S., Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence (2014) Oncotarget, 5, pp. 4154-4169. , PMID: 24980826
Carriero, M.V., Stoppelli, M.P., The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling (2011) Curr Pharm Des, 17, pp. 1944-1961. , PMID: 21711235
Resnati, M., Pallavicini, I., Wang, J.M., Oppenheim, J., Serhan, C.N., Romano, M., The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R (2002) Proc Natl Acad Sci USA, 99, pp. 1359-1364. , PMID: 11818541
Gargiulo, L., Longanesi-Cattani, I., Bifulco, K., Franco, P., Raiola, R., Campiglia, P., Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide (2005) J Biol Chem, 280, pp. 25225-25232. , PMID: 15866865
Bifulco, K., Longanesi-Cattani, I., Gala, M., Di Carluccio, G., Masucci, M.T., Pavone, V., The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence (2010) J Thromb Haemost, 8, pp. 2789-2799. , PMID: 20880257
Furlan, F., Orlando, S., Laudanna, C., Resnati, M., Basso, V., Blasi, F., The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion (2004) J Cell Sci, 117, pp. 2909-2916. , PMID: 15173320
Montuori, N., Carriero, M.V., Salzano, S., Rossi, G., Ragno, P., The cleavage of the urokinase receptor regulates its multiple functions (2002) J Biol Chem, 277, pp. 46932-46939. , PMID: 12297505
Yuan, C., Huang, M., Does the urokinase receptor exist in a latent form? (2007) Cell Mol Life Sci, 64, pp. 1033-1037. , PMID: 17372678
Gardsvoll, H., Jacobsen, B., Kriegbaum, M.C., Behrendt, N., Engelholm, L., Østergaard, S., Conformational regulation of urokinase receptor function: Impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction (2011) J Biol Chem, 286, pp. 33544-33556. , PMID: 21799009
Barinka, C., Parry, G., Callahan, J., Shaw, D.E., Kuo, A., Bdeir, K., Structural basis of interaction between urokinase-type plasminogen activator and its receptor (2006) J Mol Biol, 363, pp. 482-495. , PMID: 16979660
Xu, X., Gårdsvoll, H., Yuan, C., Lin, L., Ploug, M., Huang, M., Crystal structure of the urokinase receptor in a ligand-free form (2012) J Mol Biol, 416, pp. 629-641. , PMID: 22285761
Carriero, M.V., Longanesi-Cattani, I., Bifulco, K., Maglio, O., Lista, L., Barbieri, A., Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis (2009) Mol Cancer Ther, 8, pp. 2708-2717. , PMID: 19706734
Carriero, M.V., Bifulco, K., Minopoli, M., Lista, L., Maglio, O., Mele, L., UPARANT: A urokinase receptorderived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency (2014) Mol Cancer Ther, 13, pp. 1092-1104. , PMID: 24705350
Gao, J.L., Murphy, P.M., Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains (1993) J Biol Chem, 268, pp. 25395-25401. , PMID: 8244972
Tsubota, Y., Frey, J.M., Tai, P.W., Welikson, R.E., Raines, E.W., Monocyte ADAM17 promotes diapedesis during transendothelial migration: Identification of steps and substrates targeted by metalloproteinases (2013) J Immunol, 190, pp. 4236-4244. , PMID: 23479224
Ronald, J.A., Ionescu, C.V., Rogers, K.A., Sandig, M., Differential regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1 and VCAM-1/VLA-4 (2001) J Leukoc Biol, 70, pp. 601-609. , PMID: 11590197
Mackay, C.R., Moving targets: Cell migration inhibitors as new anti-inflammatory therapies (2008) Nat Immunol, 9, pp. 988-998. , PMID: 18711436
Salmi, M., Jalkanen, S., Ectoenzymes controlling leukocyte traffic (2012) Eur J Immunol, 42, pp. 284-292. , PMID: 22359101
Blasi, F., uPA, uPAR, PAI-1: Key intersection of proteolytic, adhesive and chemotactic highways? (1997) Immunol Today, 18, pp. 415-417. , PMID: 9293155
Miettinen, H.M., Mills, J.S., Gripentrog, J.M., Dratz, E.A., Granger, B.L., Jesaitis, A.J., The ligand binding site of the formyl peptide receptor maps in the transmembrane region (1997) J Immunol, 159, pp. 4045-4054. , PMID: 9378994
Le, Y., Murphy, P.M., Wang, J.M., Formyl-peptide receptors revisited (2002) Trends Immunol, 23, pp. 541-548. , PMID: 12401407
Bae, Y.S., Song, J.Y., Kim, Y., He, R., Ye, R.D., Kwak, J.Y., Differential activation of formyl peptide receptor signaling by peptide ligands (2003) Mol Pharmacol, 64, pp. 841-847. , PMID: 14500740
Lee, H.Y., Kim, S.D., Baek, S.H., Choi, J.H., Bae, Y.S., Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation (2013) Biochem Biophys Res Commun, 433, pp. 255-259. , PMID: 23500463
Liu, M., Zhao, J., Chen, K., Bian, X., Wang, C., Shi, Y., Wang, J.M., G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma (2012) Int Immunopharmacol, 14, pp. 283-288. , PMID: 22863814
Montuori, N., Bifulco, K., Carriero, M.V., La Penna, C., Visconte, V., Alfano, D., The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor (2011) Cell Mol Life Sci, 68, pp. 2453-2467. , PMID: 20972812
Rao, T., Ruiz-Gómez, G., Hill, T.A., Hoang, H.N., Fairlie, D.P., Mason, J.M., Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1 (2013) Plos One, 8, p. e59415. , PMID: 23544065
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(288 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote